India Bans 16 Fixed-Dose Combination Drugs Over Safety and Efficacy Concerns
The Indian government has banned the manufacture, sale, and distribution of 16 fixed-dose combination (FDC) drugs, citing lack of therapeutic justification and potential health risks. This decision follows a Supreme Court-mandated review by the Drugs Technical Advisory Board and an expert committee, which found these combinations irrational and unsupported by scientific evidence. The banned drugs span various categories, including antibiotics, painkillers, antispasmodics, and dermatological preparations, aiming to promote rational medicine use and safeguard public health.